Next Quarterly Earnings
Wednesday, November 4, 2026
CW 45
Pre-Market
In 69 days
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Astellas Pharma
Astellas Pharma is a global pharmaceutical company headquartered in Japan, dedicated to researching, developing, and manufacturing innovative medicines. With a strong focus on patient health, Astellas actively engages in pioneering therapeutic areas such as oncology, immunology, and cell and gene therapies.
Frequently asked questions
When will Astellas Pharma report its next quarterly earnings?
Astellas Pharma is scheduled to report its next quarterly earnings on 11/04/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
When did Astellas Pharma last report quarterly earnings?
Astellas Pharma last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at 79.15 JPY.
How does Astellas Pharma stock react to earnings?
Across its last 5 earnings reports, Astellas Pharma stock moved by ±1.5% on average the following day. The largest reaction was -3.3% on 04/27/2026; 3 of 5 reactions were positive.
How often has Astellas Pharma beaten expectations?
Astellas Pharma has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
How do I add the Astellas Pharma earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±1.5%
Avg. next-day move
-3.3%
Largest move (04/27/2026)
60%
Share of positive reactions
±7.5%
Avg. move after 7 days
Basis: price reactions to the last 5 report dates (close to close).
Estimates vs. results
4/5
Quarters above estimates
80%
Beat rate
+12.1%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Astellas Pharma
Country
🇯🇵
More Financial Information